Xiang Y - Search Results

1

A combination of pharmacophore modeling, molecular docking and virtual screening for iNOS inhibitors from Chinese herbs.

Wang X, Ren Z, He Y, Xiang Y, Zhang Y, Qiao Y. Wang X, et al. Among authors: xiang y. Biomed Mater Eng. 2014;24(1):1315-22. doi: 10.3233/BME-130934. Biomed Mater Eng. 2014. PMID: 24212027

2

Topomer CoMFA and virtual screening studies of azaindole class renin inhibitors.

Xiang Y, Song J, Zhang Z. Xiang Y, et al. Comb Chem High Throughput Screen. 2014;17(5):458-72. doi: 10.2174/1386207317666140107094708. Comb Chem High Throughput Screen. 2014. PMID: 24392830

3

Virtual Screening and Molecular Dynamics Study of Potential Negative Allosteric Modulators of mGluR1 from Chinese Herbs.

Jiang L, Zhang X, Chen X, He Y, Qiao L, Zhang Y, Li G, Xiang Y. Jiang L, et al. Among authors: xiang y. Molecules. 2015 Jul 15;20(7):12769-86. doi: 10.3390/molecules200712769. Molecules. 2015. PMID: 26184151 Free PMC article.

4

Discovery of Dual ETA/ETB Receptor Antagonists from Traditional Chinese Herbs through in Silico and in Vitro Screening.

Wang X, Zhang Y, Liu Q, Ai Z, Zhang Y, Xiang Y, Qiao Y. Wang X, et al. Among authors: xiang y. Int J Mol Sci. 2016 Mar 16;17(3):389. doi: 10.3390/ijms17030389. Int J Mol Sci. 2016. PMID: 26999111 Free PMC article.

5

Discovery of Potential Orthosteric and Allosteric Antagonists of P2Y1R from Chinese Herbs by Molecular Simulation Methods.

Zhang X, Lu F, Chen YK, Luo GG, Jiang LD, Qiao LS, Zhang YL, Xiang YH. Zhang X, et al. Evid Based Complement Alternat Med. 2016;2016:4320201. doi: 10.1155/2016/4320201. Epub 2016 Aug 21. Evid Based Complement Alternat Med. 2016. PMID: 27635149 Free PMC article.

6

Pharmacophore and QSAR studies to design novel histone deacetylase 2 inhibitors.

Xiang Y, Hou Z, Zhang Z. Xiang Y, et al. Chem Biol Drug Des. 2012 May;79(5):760-70. doi: 10.1111/j.1747-0285.2012.01341.x. Epub 2012 Feb 15. Chem Biol Drug Des. 2012. PMID: 22268420

7

A novel two-step QSAR modeling work flow to predict selectivity and activity of HDAC inhibitors.

Zhao L, Xiang Y, Song J, Zhang Z. Zhao L, et al. Among authors: xiang y. Bioorg Med Chem Lett. 2013 Feb 15;23(4):929-33. doi: 10.1016/j.bmcl.2012.12.067. Epub 2013 Jan 3. Bioorg Med Chem Lett. 2013. PMID: 23321563

8

3D-QSAR and docking studies of 3-arylquinazolinethione derivatives as selective estrogen receptor modulators.

Xiao A, Zhang Z, An L, Xiang Y. Xiao A, et al. Among authors: xiang y. J Mol Model. 2008 Feb;14(2):149-59. doi: 10.1007/s00894-007-0264-x. Epub 2008 Jan 3. J Mol Model. 2008. PMID: 18172701

9

Exploration of interaction of canthaxanthin with human serum albumin by spectroscopic and molecular simulation methods.

Jia J, Wang Y, Liu Y, Xiang Y. Jia J, et al. Among authors: xiang y. Luminescence. 2018 Mar;33(2):425-432. doi: 10.1002/bio.3430. Epub 2017 Dec 18. Luminescence. 2018. PMID: 29251407

10

3D-QSAR study of hallucinogenic phenylalkylamines by using CoMFA approach.

Zhang Z, An L, Hu W, Xiang Y. Zhang Z, et al. Among authors: xiang y. J Comput Aided Mol Des. 2007 Apr;21(4):145-53. doi: 10.1007/s10822-006-9090-y. Epub 2007 Jan 4. J Comput Aided Mol Des. 2007. PMID: 17203365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,016 results

Search Page

Filters